Your browser doesn't support javascript.
loading
Proceedings of the dengue endgame summit: Imagining a world with dengue control.
Wegman, Adam D; Kalimuddin, Shirin; Marques, Ernesto T A; Adams, Laura E; Rothman, Alan L; Gromowski, Gregory D; Wang, Taia T; Weiskopf, Daniela; Hibberd, Martin L; Alex Perkins, T; Christofferson, Rebecca C; Gunale, Bhagwat; Kulkarni, Prasad S; Rosas, Angel; Macareo, Louis; Yacoub, Sophie; Eong Ooi, Eng; Paz-Bailey, Gabriela; Thomas, Stephen J; Waickman, Adam T.
Afiliación
  • Wegman AD; Department of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, NY 13210, USA.
  • Kalimuddin S; Department of Infectious Diseases, Singapore General Hospital, Singapore; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Marques ETA; Department of Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh, PA, USA.
  • Adams LE; Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico, USA.
  • Rothman AL; Department of Cell and Molecular Biology, Institute for Immunology and Informatics, University of Rhode Island, Providence, RI, USA.
  • Gromowski GD; Viral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
  • Wang TT; Institute for Immunity, Transplantation and Infection, Stanford University, Stanford, CA, USA; Department of Medicine, Division of Infectious Diseases, Stanford University, Stanford, CA, USA; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford University, Stan
  • Weiskopf D; Center for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA 92037, USA.
  • Hibberd ML; London School of Hygiene & Tropical Medicine Department of Infection Biology, Keppel Street, London WC1E 7HT, England; Associate Faculty, National Institutes of Health, University of the Philippines, Philippines.
  • Alex Perkins T; Department of Biological Sciences, University of Notre Dame, Notre Dame, IN, USA.
  • Christofferson RC; Department of Pathobiological Sciences, Louisiana School of Veterinary Medicine, Baton Rouge, LA, USA.
  • Gunale B; Serum Institute of India Pvt. Ltd., Pune, India.
  • Kulkarni PS; Serum Institute of India Pvt. Ltd., Pune, India.
  • Rosas A; Takeda Pharmaceuticals, Inc, Boston, MA, USA.
  • Macareo L; Merck & Co., Inc., Rahway, NJ 07065, USA.
  • Yacoub S; Oxford University Clinical Research Unit (OUCRU) Ho Chi Minh City, Viet Nam; Centre for Tropical Medicine and Global Health, University of Oxford, UK.
  • Eong Ooi E; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Paz-Bailey G; Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico, USA.
  • Thomas SJ; Department of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, NY 13210, USA; Institute for Global Health and Translational Sciences, State University of New York Upstate Medical University, Syracuse, NY 13210, USA. Electronic address: ThomStep@upstate.
  • Waickman AT; Department of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, NY 13210, USA; Institute for Global Health and Translational Sciences, State University of New York Upstate Medical University, Syracuse, NY 13210, USA. Electronic address: waickmaa@upstate.
Vaccine ; 42(23): 126071, 2024 Oct 03.
Article en En | MEDLINE | ID: mdl-38890105
ABSTRACT
The first dengue "endgame" summit was held in Syracuse, NY over August 9 and 10, 2023. Organized and hosted by the Institute for Global Health and Translational Sciences at SUNY Upstate Medical University, the gathering brought together researchers, clinicians, drug and vaccine developers, government officials, and other key stakeholders in the dengue field for a highly collaborative and discussion-oriented event. The objective of the gathering was to discuss the current state of dengue around the world, what dengue "control" might look like, and what a potential roadmap might look like to achieve functional dengue control. Over the course of 7 sessions, speakers with a diverse array of expertise highlighted both current and historic challenges associated with dengue control, the state of dengue countermeasure development and deployment, as well as fundamental virologic, immunologic, and medical barriers to achieving dengue control. While sustained eradication of dengue was considered challenging, attendees were optimistic that significant reduction in the burden of dengue can be achieved by integration of vector control with effective application of therapeutics and vaccines.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Dengue / Vacunas contra el Dengue Límite: Animals / Humans Idioma: En Revista: Vaccine Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Dengue / Vacunas contra el Dengue Límite: Animals / Humans Idioma: En Revista: Vaccine Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos